Nisa Investment Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-750
| Closed | -$13K | – | 2283 |
|
|
2020
Q2 | $13K | Buy |
750
+180
| +32% | +$2.5K | ﹤0.01% | 1872 |
|
|
2020
Q1 | $4K | Sell |
570
-410
| -42% | -$5.12K | ﹤0.01% | 1993 |
|
|
2019
Q4 | $23K | Buy |
980
+660
| +206% | +$18.2K | ﹤0.01% | 1675 |
|
|
2019
Q3 | $9K | Hold |
320
| – | – | ﹤0.01% | 1825 |
|
|
2019
Q2 | $9K | Hold |
320
| – | – | ﹤0.01% | 1798 |
|
|
2019
Q1 | $11K | Hold |
320
| – | – | ﹤0.01% | 1737 |
|
|
2018
Q4 | $6K | Hold |
320
| – | – | ﹤0.01% | 1789 |
|
|
2018
Q3 | $9K | Sell |
320
-120
| -27% | -$3.92K | ﹤0.01% | 1772 |
|
|
2018
Q2 | $17K | Buy |
440
+90
| +26% | +$3.44K | ﹤0.01% | 1570 |
|
|
2018
Q1 | $11K | Hold |
350
| – | – | ﹤0.01% | 1643 |
|
|
2017
Q4 | $17K | Hold |
350
| – | – | ﹤0.01% | 1595 |
|
|
2017
Q3 | $19K | Hold |
350
| – | – | ﹤0.01% | 1549 |
|
|
2017
Q2 | $20K | Buy |
350
+100
| +40% | +$4K | ﹤0.01% | 1493 |
|
|
2017
Q1 | $10K | Sell |
250
-950
| -79% | -$30.3K | ﹤0.01% | 1684 |
|
|
2016
Q4 | $27K | Hold |
1,200
| – | – | ﹤0.01% | 1551 |
|
|
2016
Q3 | $27K | Hold |
1,200
| – | – | ﹤0.01% | 1555 |
|
|
2016
Q2 | $28K | Buy |
1,200
+400
| +50% | +$9.88K | ﹤0.01% | 1506 |
|
|
2016
Q1 | $16K | Buy |
+800
| New | +$25.4K | ﹤0.01% | 1678 |
|
Nisa Investment Advisors's PTLA Position: Q3 2020 in Review
Nisa Investment Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 750 shares — an estimated $13K sold.
Nisa Investment Advisors first reported a position in PTLA in Q1 2016 and held it in 18 quarters. The position peaked at $28K in Q2 2016. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Nisa Investment Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Nisa Investment Advisors sold 750 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $13K.
- Nisa Investment Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q1 2016 and held it in 18 quarters.
- Nisa Investment Advisors's Portola Pharmaceuticals, Inc. position peaked at $28K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Nisa Investment Advisors's 13F filing for Q3 2020, filed 20 Oct 2020.